Alternative Thinking: Both Sides of the Investment Coin
Business:Investing
Today we hear from two veterans of the biotech and pharmaceutical market - one with a mutual fund that invests in equities and uses options to tailor the trades to his liking, and another whose private fund purchases actual drug royalty streams to provide uncorrelated returns to investors.
More Episodes
AGinvest Farmland Properties & Glengarry Farm Finance
2023-07-21
558
2023-07-21
558
OSC Innovation Office & LockDocks
2023-06-01
316
2023-06-01
316
Evolve ETFs & Slate Securities
2022-10-31
336
2022-10-31
336
Firm Capital & Darren Coleman (Raymond James)
2022-08-23
286
2022-08-23
286
Aquanow & Warwick Capital
2022-08-09
271
2022-08-09
271
Defi Tech & Penrose Partners
2022-06-06
331
2022-06-06
331
Firm Capital & Darren Coleman (Raymond James)
2022-01-12
456
2022-01-12
456
FORT LP & Lyxor Asset Management
2021-06-28
873
2021-06-28
873
Alquity Investment Management & OPTrust
2021-05-03
301
2021-05-03
301
Invico Capital & LevanteLiving
2021-04-28
274
2021-04-28
274
360 Trading Networks & AGF Investments
2021-04-26
212
2021-04-26
212
Emso Asset Management & Trans-Canada Capital
2021-04-23
243
2021-04-23
243
Maxam Capital Management & James Price (Richardson Wealth)
2021-04-21
252
2021-04-21
252
CAASA & Federation of Mutual Fund Dealers
2021-04-16
233
2021-04-16
233
MM Fund & Investment Partners Fund
2021-01-13
205
2021-01-13
205
Anchor Pacific Investment Management & Forstrong Global
2021-01-12
164
2021-01-12
164
Get this podcast on your
phone, FREE
